-
1
-
-
0022085051
-
Hypothyroidism and atherosclerotic heart disease: Pathogenesis, medical management, and the role of coronary artery bypass surgery
-
Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 1985; 6: 432-40.
-
(1985)
Endocr Rev
, vol.6
, pp. 432-440
-
-
Becker, C.1
-
2
-
-
0025340611
-
Recognition and management of cardiovascular disease related to thyroid dysfunction
-
Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 1990; 88: 638-41.
-
(1990)
Am J Med
, vol.88
, pp. 638-641
-
-
Ladenson, P.W.1
-
3
-
-
0031911001
-
Thyroid hormone and cardiovascular disease
-
Gomberg-Maitland M, Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J 1998; 135: 187-96.
-
(1998)
Am Heart J
, vol.135
, pp. 187-196
-
-
Gomberg-Maitland, M.1
Frishman, W.H.2
-
4
-
-
0014249434
-
Myxedema and coronary artery disease - A comparative autopsy study
-
Steinberg AD. Myxedema and coronary artery disease - a comparative autopsy study. Ann Intern Med 1968; 68: 338-44.
-
(1968)
Ann Intern Med
, vol.68
, pp. 338-344
-
-
Steinberg, A.D.1
-
5
-
-
0005339266
-
The influence of thyroid hormones on cholesterol metabolism in experimental atherosclerosis in rabbits
-
Myasnikov AL, Myasnikov LA, Zaitzev VF. The influence of thyroid hormones on cholesterol metabolism in experimental atherosclerosis in rabbits. J Atheroscler Res 1963; 37: 295-300.
-
(1963)
J Atheroscler Res
, vol.37
, pp. 295-300
-
-
Myasnikov, A.L.1
Myasnikov, L.A.2
Zaitzev, V.F.3
-
6
-
-
0031005876
-
The effect of thyroid hormone therapy on angiographic coronary artery disease progression
-
Perk M, O'Neill BJ. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol 1997; 13: 273-6.
-
(1997)
Can J Cardiol
, vol.13
, pp. 273-276
-
-
Perk, M.1
O'Neill, B.J.2
-
7
-
-
0031686061
-
Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism
-
Martinez-Triguero ML, Hernandez-Mijares A, Nguyen TT et al. Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. Mayo Clin Proc 1998; 73: 837-41.
-
(1998)
Mayo Clin Proc
, vol.73
, pp. 837-841
-
-
Martinez-Triguero, M.L.1
Hernandez-Mijares, A.2
Nguyen, T.T.3
-
8
-
-
0031034251
-
The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E
-
O'Brien T, Katz K, Hodge D et al. The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clin Endocrinol (Oxf) 1997; 46: 17-20.
-
(1997)
Clin Endocrinol (Oxf)
, vol.46
, pp. 17-20
-
-
O'Brien, T.1
Katz, K.2
Hodge, D.3
-
9
-
-
0031934299
-
Plasma total homocysteine levels in hyperthyroid and hypothyroid patients
-
Nedrebo BG, Ericsson UB, Nygard O et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 1998; 47: 89-93.
-
(1998)
Metabolism
, vol.47
, pp. 89-93
-
-
Nedrebo, B.G.1
Ericsson, U.B.2
Nygard, O.3
-
10
-
-
0034454116
-
Plasma total homocysteine levels during short-term iatrogenic hypothyroidism
-
Lien EA, Nedrebo BG, Varhaug JE et al. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab 2000; 85: 1049-53.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 1049-1053
-
-
Lien, E.A.1
Nedrebo, B.G.2
Varhaug, J.E.3
-
11
-
-
0034872102
-
Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment
-
Nedrebo BG, Nygard O, Ueland PM, Lien EA. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clin Chem 2001; 47: 1738-41.
-
(2001)
Clin Chem
, vol.47
, pp. 1738-1741
-
-
Nedrebo, B.G.1
Nygard, O.2
Ueland, P.M.3
Lien, E.A.4
-
12
-
-
0035093259
-
Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism
-
Chadarevian R, Bruckert E, Leenhardt L et al. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001; 86: 732-7.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 732-737
-
-
Chadarevian, R.1
Bruckert, E.2
Leenhardt, L.3
-
13
-
-
0038076459
-
What is the target TSH level in thyroid hormone replacement for primary hypothyroidism?
-
Zimmerman RS. What is the target TSH level in thyroid hormone replacement for primary hypothyroidism? Cleve Clin J Med 2003; 70: 329-30.
-
(2003)
Cleve Clin J Med
, vol.70
, pp. 329-330
-
-
Zimmerman, R.S.1
-
14
-
-
0034888086
-
Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients
-
McDermott MT, Haugen BR, Lezotte DC et al. Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients. Thyroid 2001; 11: 757-64.
-
(2001)
Thyroid
, vol.11
, pp. 757-764
-
-
McDermott, M.T.1
Haugen, B.R.2
Lezotte, D.C.3
-
15
-
-
0008313174
-
Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease, 2002 Washington, DC
-
National Academy of Clinical Biochemistry
-
Demers LM, Spencer CA. Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease, 2002 Washington, DC. In National Academy of Clinical Biochemistry (http://www.nacb.org).
-
-
-
Demers, L.M.1
Spencer, C.A.2
-
16
-
-
0036858505
-
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism
-
American Association of Clinical Endocrinologists
-
American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457-69.
-
(2002)
Endocr Pract
, vol.8
, pp. 457-469
-
-
-
17
-
-
24344495292
-
The evidence for a narrower thyrotropin reference range is compelling
-
Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90: 5483-8.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 5483-5488
-
-
Wartofsky, L.1
Dickey, R.A.2
-
18
-
-
26944488996
-
Optimal thyrotropin level: Normal ranges and reference intervals are not equivalent
-
Dickey RA, Wartofsky L, Feld S. Optimal thyrotropin level: Normal ranges and reference intervals are not equivalent. Thyroid 2005; 15: 1035-9.
-
(2005)
Thyroid
, vol.15
, pp. 1035-1039
-
-
Dickey, R.A.1
Wartofsky, L.2
Feld, S.3
-
20
-
-
0025756673
-
Hyperhomocysteinemia: An independent risk factor for vascular disease
-
Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55.
-
(1991)
N Engl J Med
, vol.324
, pp. 1149-1155
-
-
Clarke, R.1
Daly, L.2
Robinson, K.3
-
22
-
-
0033533444
-
Normalization of hyperhomocysteinemia with 1-thyroxine in hypothyroidism
-
Hussein WI, Green R, Jacobsen DW, Faiman C. Normalization of hyperhomocysteinemia with 1-thyroxine in hypothyroidism. Ann Intern Med 1999; 131: 348-51.
-
(1999)
Ann Intern Med
, vol.131
, pp. 348-351
-
-
Hussein, W.I.1
Green, R.2
Jacobsen, D.W.3
Faiman, C.4
-
23
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
Rifai, N.4
-
24
-
-
0037300574
-
Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial
-
Christ-Crain M, Meier C, Guglielmetti M et al. Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 2003; 166: 379-86.
-
(2003)
Atherosclerosis
, vol.166
, pp. 379-386
-
-
Christ-Crain, M.1
Meier, C.2
Guglielmetti, M.3
-
25
-
-
0035106201
-
Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease
-
Muller B, Tsakiris DA, Roth CB et al. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 2001; 31: 131-7.
-
(2001)
Eur J Clin Invest
, vol.31
, pp. 131-137
-
-
Muller, B.1
Tsakiris, D.A.2
Roth, C.B.3
-
26
-
-
0031964035
-
Relationship between thyroid hormones and plasma D-dimer levels
-
Chadarevian R, Bruckert E, Ankri A et al. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998; 79: 99-103.
-
(1998)
Thromb Haemost
, vol.79
, pp. 99-103
-
-
Chadarevian, R.1
Bruckert, E.2
Ankri, A.3
-
27
-
-
0037347519
-
Blood coagulation and fibrinolytic activity in hypothyroidism
-
Erem C, Kavgaci H, Ersoz HO et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 2003; 57: 78-81.
-
(2003)
Int J Clin Pract
, vol.57
, pp. 78-81
-
-
Erem, C.1
Kavgaci, H.2
Ersoz, H.O.3
-
28
-
-
0030875234
-
Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values
-
Lekakis J, Papamichael C, Alevizaki M et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7: 411-4.
-
(1997)
Thyroid
, vol.7
, pp. 411-414
-
-
Lekakis, J.1
Papamichael, C.2
Alevizaki, M.3
|